Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Starting soon Not applicable

Point-of-Care Ultrasound for Diagnosing Abdominal Pain in the Emergency Department

NCT07849569 · tracked via the Priya Life Science Denmark tracker
Phase
Not applicable
Started
2026-10-01
Last updated
2026-09-30

Condition(s) studied

Emergency MedicinePOCUSAbdominal Pain (AP)Acute Abdominal PainUltrasound

Investigational drug(s) / intervention(s)

Point of care ultrasound

Point of care ultrasound: The abdominal point-of-care ultrasound examination is performed by the enrolling emergency physician at the bedside, as part of the initial assessment, rather than by a radiologist or sonographer. The examination follows a standardized scanning protocol developed by the study steering committee, covering conditions that are common or critical in the emergency department, accessible to point-of-care ultrasound, and supported by evidence on diagnostic accuracy. The examination typically takes 5 to 10 minutes. Findings may guide further diagnostics or treatment at the physician's discretion.

Study summary

The goal of this clinical trial is to learn if adding an abdominal ultrasound scan to the standard examination helps emergency physicians make a correct diagnosis in adults with acute abdominal pain in the emergency department. The main question it aims to answer is:

Does adding an abdominal point of care ultrasound scan to the standard examination increase the number of patients with acute abdominal pain in the emergency department, who get a correct preliminary diagnosis?

Researchers will compare patients examined with an abdominal point-of-care ultrasound scan in addition to the standard examination to patients examined with the standard examination alone, to see if adding ultrasound improves diagnostic accuracy.

Participants will:

* Be randomly assigned to also have an abdominal point-of-care ultrasound scan performed by their doctor, or not
* Have their doctor record a preliminary diagnosis and differential diagnosis
* Have their medical records reviewed by an independent panel 30 days after their visit, to determine their final diagnosis

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: 1. ED contact. 2. Age ≥18 years. 3. Non-traumatic, acute abdominal pain, defined as symptom onset ≤7 days prior to presentation, as chief complaint. 4. Ability to provide written informed consent, as judged by the enrolling physician, and to communicate in Danish or English. Exclusion Criteria: 1. Prior enrollment in the trial. 2. Patients in whom the cause of the current abdominal pain is considered known at the time of enrolment (previously diagnosed condition explaining the current symptoms, e.g. known symptomatic gallstone disease). 3. Prior physician assessment of the presenting abdominal complaint during the current ED visit. 4. Prior ED assessment or received an abdominal ultrasound or CT scan for the same complaint, within the preceding 7 days. 5. Chronic abdominal pain, defined as abdominal pain persisting or recurring for ≥3 months(17), where the current episode represents an exacerbation of the chronic condition. 6. Patients requiring immediate critical care or rapid-response team activation.

Primary outcome measure(s)

  • Correct preliminary diagnosis — From enrollment to after 30 days
    The primary outcome is the correct preliminary diagnosis, defined as agreement between the enrolling physician's preliminary diagnosis and the final adjudicated diagnosis.

Trial sites (3)

FacilityCityRegionStatus
Esbjerg Akutafdeling Esbjerg Denmark
Horsens Akutafdeling Horsens Denmark
Køge Akutafdeling Køge Denmark
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07849569 on ClinicalTrials.gov ↗ ← All trials in Denmark